Click Here to return To Results

 

Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin Cardiovasc Drugs Ther 15:211-218, Bernini,F.,et al, 2001 See this aricle in Pubmed Article Abstract No abstract available for this article

Related Tags

(click to filter results - removes previous filter) adverse drug reaction atorvastatin creatine phosphokinase(CPK)elevated HMGcoA reductase inhibitors lipid lowering agent myopathy myopathy,drug-induced myopathy,toxic rhabdomyolysis statin therapy

Click Here to return To Results